Please assess the completion status of the following clinical trial:

Trial Title: Moxifloxacin in the Prevention of Bacteremia After High-dose Chemotherapy and Transplantation of Peripheral Stem Cells

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* High-dose chemotherapy followed by peripheral autologous stem cell transplantation~* Underlying disease: Hodgkin Disease, non-Hodgkin-lymphoma, multiple myeloma or solid tumor~Exclusion Criteria:~* Allogenic stem cell transplantation~* Aplastic anemia~* Antibiotic treatment within seven days prior to randomization~* Signs and symptoms of current infection

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 75 Years
- Healthy Volunteers: f

Study Arms:
- Moxifloxacin (Type: EXPERIMENTAL): moxifloxacin 400 mg tablets once daily
- Placebo (Type: PLACEBO_COMPARATOR): identical appearing placebo

Based on this trial design, predict the completion outcome and termination type (if applicable).